One of the most confusing things about PMDD is being told that your hormone levels are normal when your symptoms feel anything but normal.
You may experience severe anxiety, depression, irritability, brain fog, exhaustion or physical
symptoms at almost the same point every month. Then a hormone panel comes back within the expected range.
For years, this has contributed to the idea that if nothing unusual shows up in your blood work, hormones cannot be responsible for what you are experiencing.
PMDD research points to a different explanation. The problem may not be the amount of hormone in your blood, but what happens in the brain as those hormones rise and fall.
The brain responds to hormonal change
Estrogen and progesterone naturally fluctuate across the menstrual cycle. After ovulation,
progesterone rises and is converted into several neuroactive metabolites, including
allopregnanolone, or ALLO.
ALLO acts on GABA-A receptors in the brain.
GABA is the brain's main inhibitory neurotransmitter. One simple way to think about it is as part of the brain's braking system. It helps reduce excessive neural activity, quieten stress responses and prevent the brain's emotional alarm systems from running unchecked.
ALLO normally strengthens this braking effect.
The brain also has systems that act more like an accelerator. They help us react quickly to stress, threat and emotionally important situations. We need both. A healthy nervous system is constantly adjusting the balance between the accelerator and the brake.
In PMDD, research suggests that the brain may have difficulty adapting to the normal rise and fall of ALLO across the cycle. Changes that would normally help regulate the nervous system can instead be associated with anxiety, irritability, emotional reactivity and other PMDD symptoms.
So the hormones themselves can be completely normal while the response to them is not.
When the brake becomes less reliable
This may help explain why PMDD can feel so sudden.
During one part of the month, the brain may be regulating stress and emotion relatively well. Then hormonal conditions change after ovulation and the same nervous system begins responding differently.
The emotional accelerator can start getting ahead of the brake.
A stressful situation may feel more threatening. Irritation can escalate much faster. A small setback may become overwhelming, and once the nervous system is highly activated, it can become much harder to step back and put the situation into perspective.
This is one reason PMDD is increasingly understood as a disorder of neurohormonal sensitivity rather than a simple hormone imbalance.
Why a hormone test cannot show this
A blood test can tell you how much estrogen or progesterone was circulating when the sample was taken.
It cannot measure how your brain is adapting to those hormones or how GABA-A receptors are responding to changes in neurosteroids such as ALLO.
PMDD is also fundamentally cyclical. The important information is often found in the pattern: symptoms emerge after ovulation, intensify during the premenstrual phase and then improve within the first few days of menstruation.
There is currently no blood, saliva or urine test that can diagnose PMDD. Hormone testing can still be useful for ruling out other conditions, but normal results are entirely compatible with PMDD.
This is why daily symptom tracking across at least two cycles remains such an important part of diagnosis.
Your blood work can be normal while your experience is very real
For someone who has spent years being told that their tests are normal, learning this can change the way PMDD makes sense.
The symptoms are not evidence that your hormones are necessarily “out of balance,” and they are not happening because you are failing to cope with ordinary hormonal changes.
The same hormonal fluctuations that most menstrual cycles contain can produce a very different response in a brain that is unusually sensitive to them.
Sometimes the missing piece is not visible in the amount of hormone in the blood. It is in the way the brain responds when those hormones change.
Sources:
Hantsoo L, Epperson CN. Allopregnanolone in premenstrual dysphoric disorder (PMDD):
Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiology of Stress, 2020.
Liu B. et al. Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development. Frontiers in Psychiatry, 2023.
International Association for Premenstrual Disorders (IAPMD): What is PMDD? and diagnostic resources.
